Protective Effect of Benidipine Against the Abnormal Electrical Activity in Single Ventricular Myocytes of the Guinea Pig Under Simulated Ischemic Conditions and Reperfusion.
-
- Tokuno Tomoaki
- Department of Pharmacology & Therapeutics Faculty of Pharmaceutical Sciences,Nagoya City University,3-1 Tanabedori,Mizuhoku,Nagoya 467-8603,Japan
-
- Muraki Katsuhiko
- Department of Chemical Pharmacology,Facultyof Pharmaceutical Sciences,Nagoya City University,3-1 Tanabedori,Mizuhoku,Nagoya 467-8603,Japan
-
- Watanabe Minoru
- Department of Chemical Pharmacology,Facultyof Pharmaceutical Sciences,Nagoya City University,3-1 Tanabedori,Mizuhoku,Nagoya 467-8603,Japan
-
- Imaizumi Yuji
- Department of Pharmacology & Therapeutics Faculty of Pharmaceutical Sciences,Nagoya City University,3-1 Tanabedori,Mizuhoku,Nagoya 467-8603,Japan
この論文をさがす
説明
Induction of electrical abnormalities(EAs)under simulated ischemic conditions and after reperfusion was measured from single cardiac myocytes isolated from guinea pig ventricle using whole-cell voltage or current clamp with perforated patch variation.Conditions of simulated ischemia were produced by the exchange of medium from the standard one oxygenated with 95%O2−5%CO2 gas(pH7.4)to the modified one, which contained no glucose, 8mM K+ and 30mM sodium-D, L-lactate and was gassed with 90% argon −10%CO2(pH6.6).Under the simulated ischemia for 20min, EAs such as delayed afterdepolarization, early afterdepolarization, automatic activity or transient inward current were observed in about 37% of myocytes driven electrically at 1Hz.Irreversible hypercontracture occurred in myocytes of 10% or less.Upon reperfusion with the standard solution, EAs and hypercontracture were oberved in about 43% and 22% of cells, respectively.Glibenclamide-sensitive current was detected during ischemia, but tended to be enhanced during reperfusion.Amplitude of Ca2+ current and ATP-sensitive K+ current after reperfusion varied widely with time and from cell to cell.When myocytes were pretreated for 10min with 10nM benidipine, a 1, 4-dihydropyridine derivative Ca2+ blocker, the incidence of EAs and hypercontracture was markedly reduced, suggesting the protective effect of benidipine against cardiac cell injury during ischemia and reperfusion.
収録刊行物
-
- Jpn.J.Pharmacol.
-
Jpn.J.Pharmacol. 82 (3), 199-209, 2000
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204284873088
-
- NII論文ID
- 10008183423
-
- NII書誌ID
- AA00691188
-
- COI
- 1:CAS:528:DC%2BD3cXitFOiur4%3D
-
- ISSN
- 13473506
- 00215198
-
- NDL書誌ID
- 5320979
-
- PubMed
- 10887950
-
- Web Site
- http://id.ndl.go.jp/bib/5320979
- https://ndlsearch.ndl.go.jp/books/R000000004-I5320979
- https://api.elsevier.com/content/article/PII:S0021519819306857?httpAccept=text/xml
- https://api.elsevier.com/content/article/PII:S0021519819306857?httpAccept=text/plain
- https://www.jstage.jst.go.jp/article/jjp/82/3/82_3_199/_pdf
- https://search.jamas.or.jp/link/ui/2000174836
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可